SciTransfer
Organization

TETHIS SPA

Italian deep-tech SME engineering nanostructured surfaces for PGM-free fuel cell catalysts and circulating tumor cell diagnostics.

Technology SMEmanufacturingITSMENo active H2020 projectsThin data (2/5)
H2020 projects
2
As coordinator
1
Total EC funding
€362K
Unique partners
9
What they do

Their core work

TETHIS is a Milan-based materials technology SME specializing in advanced nanostructured surface engineering, applied across two distinct domains: clean energy catalysis and biomedical diagnostics. In energy, they work on designing transition metal nanoparticle catalysts as replacements for expensive platinum-group metals (PGMs) in fuel cells and electrocatalytic applications, combining experimental synthesis with machine learning-assisted materials screening and first-principles simulations. In diagnostics, they develop surface-based platforms for detecting and characterizing circulating tumor cells, suggesting their nanostructured surface expertise is transferable across industries. This dual application of the same core competency — engineering functional surfaces at the nanoscale — is what makes them unusual among Italian deep-tech SMEs.

Core expertise

What they specialise in

Electrocatalysis and PGM-free catalyst designprimary
1 project

CritCat (2016-2019) placed TETHIS in a multinational RIA consortium working on rational design of nanoparticle catalysts to replace critical platinum-group materials in fuel cell electrodes.

Transition metal nanoparticle synthesis and controlprimary
1 project

CritCat keywords cite 'transition metal nanoparticles' and 'nanoparticle control' as core deliverables, indicating hands-on material fabrication capability.

Computational materials screening and ML for materialssecondary
1 project

CritCat involvement included machine learning and first-principles simulations for materials screening, suggesting TETHIS contributes computational as well as experimental expertise.

Biomedical diagnostic surface platformsemerging
1 project

TETHIS-SBS-CTC (2018), which TETHIS coordinated under SME Instrument Phase 1, targeted an innovative platform for isolating and characterizing circulating tumor cells — a distinct but surface-engineering-adjacent application.

Evolution & trajectory

How they've shifted over time

Early focus
Electrocatalysis and fuel cell materials
Recent focus
Circulating tumor cell diagnostics

TETHIS entered H2020 through CritCat (2016) squarely in the clean energy materials space — electrocatalysis, fuel cells, and PGM replacement — applying both experimental nanoparticle work and computational tools. By 2018 they were simultaneously pursuing a self-led SME Instrument project in cancer diagnostics, indicating a deliberate pivot to commercializing their surface engineering know-how in the biomedical market. The absence of keywords in the second project and the short SME-1 duration (within-year, 2018–2018) suggest this was an early-stage feasibility study rather than a mature product, so the biomedical thread may still be exploratory rather than established.

TETHIS appears to be moving from foundational energy-materials research participation toward proprietary diagnostic product development, using their nanostructured surface platform as a horizontal technology across sectors.

Collaboration profile

How they like to work

Role: specialist_contributorReach: European5 countries collaborated

TETHIS has operated both as a consortium participant (CritCat RIA, alongside likely academic and larger industrial partners) and as a project coordinator (TETHIS-SBS-CTC SME-1, where they drove their own commercial pitch). Their small total partner count (9 unique partners across just 2 projects) suggests they work in focused, compact teams rather than large open consortia. This profile is typical of a technology-product SME that joins research consortia for access to expertise and then leads when commercializing its own IP.

TETHIS has built connections with 9 partners across 5 European countries through two projects, suggesting a functional but limited network concentrated around their two application domains. No evidence of repeated partnerships with the same organizations, so their network is breadth-first rather than relationship-deep.

Why partner with them

What sets them apart

TETHIS occupies an unusual position as an SME that applies the same nanostructured surface engineering platform to both clean energy (fuel cell catalysts) and oncology diagnostics (tumor cell capture) — making them one of the few Italian SMEs with genuine cross-sector deep-tech credentials. Their combination of ML-assisted materials design with experimental nanofabrication is rare at SME scale and positions them as a credible bridge between computational materials science and industrial application. For consortium builders, they bring proprietary platform technology rather than generic research capacity, which is more valuable in exploitation-oriented projects.

Notable projects

Highlights from their portfolio

  • CritCat
    Largest funding received (€311,596), tackling the high-priority challenge of replacing scarce platinum-group metals in fuel cells — directly relevant to the EU's critical raw materials agenda and clean hydrogen economy.
  • TETHIS-SBS-CTC
    TETHIS acted as coordinator and sole named entity in this SME Instrument Phase 1 project, meaning this was their own commercial concept — a diagnostic platform for circulating tumor cells — rather than a collaborative research role.
Cross-sector capabilities
health — diagnostic device development and biomedical surface engineeringenergy — fuel cell catalysts and electrochemical systemsdigital — machine learning applied to materials discovery
Analysis note: Only 2 projects in a short window (2016-2018) with very limited keyword data on the second project. The dual-domain profile (energy + diagnostics) is intriguing but may reflect opportunistic early-stage exploration rather than established dual expertise. The second project (SME-1) was a short feasibility study with no associated keywords — its actual technical content is inferred from the title alone. Any collaboration assessment should be validated against the organization's current website and recent activity beyond H2020.
More in Manufacturing & Industry 4.0
See all Manufacturing & Industry 4.0 organizations